The production of insulin-like growth factor-binding protein-1 (IGFBP-1) in HepG2 was increased by cadmium cation (Cd 2þ ) at 3 M, but not by other divalent cations. The mRNA level of IGFBP-1 was also increased by the administration of 3 M of Cd 2þ . These results suggest that Cd 2þ impacts the gene expression of IGFBP-1, which leads to production of IGFBP-1.
Insulin-like growth factor-binding proteins (IGFBPs) are complexed with insulin-like growth factor-I (IGF-I). IGF-I has biological effects, including stimulation of DNA synthesis and protein synthesis. 1, 2) IGFBPs regulate the bioactivities of IGF-I. 1) Cadmium is a toxic element found in most types of food. Some foods, such as rice and forum wheat, are natural bioaccumulators of cadmium via a variety of routes of exposure. 3, 4) Oral administration of cadmium causes anemia due to a deficiency of iron (75 ppm after 14 d) 5) and is a hepatotoxin. 6) It has been found that exposure to cadmium increases IGFBP-5 mRNA 7) and decreases plasma IGF-I and IGFBP-3 levels. 8) The plasma concentration of IGFBP-1 is increased by protein-deprivation and the administration of glucocorticoids, 9, 10) but the effect of cadmium on IGFBP-1 is not known. In the present study, we investigated the effects of cadmium cation (Cd 2þ ) on the production of IGFBP-1 in a human hepatocellular carcinoma cell line, HepG2. Further, the levels of IGFBP-1 mRNA were examined by quantitative PCR. Our results indicate that treatment of HepG2 with 3 mM Cd 2þ causes a drastic increase in the mRNA levels of IGFBP-1, concomitant with a boost in the production of IGFBP-1.
HepG2 cells were plated on 35 mm dish plates (1:0 Â 10 6 cells/dish) and cultured in DMEM/Nutrient Mixture F-12 Ham medium (Sigma, St. Louis, MO) with 10% FBS (JRH, Nissui, Tokyo) under 95% air-5% CO 2 until they were confluent. The cells were incubated in 1 ml of DMEM/Nutrient Mixture F-12 Ham medium with 1% FBS containing 0 to 100 mM cadmium chloride (Wako Pure Chemical Industries, Tokyo). The amount of IGFBP-1 in 20 ml of the conditioned medium was measured by immunoblot analysis, as described previously.
11)
The blots were detected with an anti-IGFBP-1 polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA), and then anti-goat Ig-horseradish peroxidase (Chemicon International, Temecula, CA). Extraction of total RNA and synthesis of complementary DNA were performed as described previously. 12) Quantitative PCR primers and hybridization probes were synthesized by Applied Biosystems (Foster, IN) . The oligonucleotide primers of IGFBP-1 were designed to amplify nucleo- A time course analysis indicated that the production of IGFBP-1 was increased significantly in HepG2 cells exposed to a 3 mM Cd 2þ for 72 and 144 h (data not shown). Cd 2þ at 0.1 to 10 mM (0.01 to 1.12 ppm) increased the amount of IGFBP-1 in HepG2 cells significantly for 72 h (1.4 fold of the control at 0.1 mM, 3.9 fold at 3 mM, and 1.9 fold at 10 mM) (Fig. 1A) . Cell numbers did not change significantly at 0.1 to 3 mM of Cd 2þ according to the 3-[4,5-dimethyl-2-thiazoyl]-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay (Fig. 1B) . 13) The production of IGFBP-1 at 10 mM Cd 2þ was lower than that at 3 mM, which was conceivably due to the decrease in cell numbers. Cd 2þ at 30 mM and 100 mM drastically decreased the viability of HepG2. As shown in Fig. 2 , the treatment with Cd 2þ at 3 mM increased the mRNA level of IGFBP-1 at 16 h, 24 h, 36 h, and 72 h, but not 6 h (5.6-, 2.9-, 1.9-, and 2.6-fold of the control respectively, 0.78 fold at 6 h). This experiment was run three times. Other divalent cations, iron, zinc, lead, mercury, and tin, did not significantly increase IGFBP-1 production at 0.1 to 10 mM (Fig. 3) . These results suggest that Cd 2þ specifically increases the amount of IGFBP-1. We found that a low dose of Cd 2þ increased the mRNA levels of IGFBP-1 in HepG2, which resulted in a marked rise in the amount of IGFBP-1 protein produced ( Figs. 1 and 2 ). IGFBP-1 inhibits the activities of IGF-I. In demonstrating the bioavailability of IGF-I, however, measuring not only the amount of IGFBP-1 but also those of free-IGF-I and the other IGFBPs in conditioned HepG2 cells were cultured with 3 mM of cadmium chloride for 0, 6, 16, 24, 36, and 72 h. After total RNA was extracted from the HepG2 cells, the mRNA level of IGFBP-1 was analyzed by quantitative PCR. Control was a group receiving 0 mM additional Cd medium would be of help. Cd 2þ at 7.5 mM, but not zinc, induces upstream stimulatory factors (USFs).
14) The increased binding of USFs to the promoter of IGFBP-1 results in elevated expression of the IGFBP-1 gene.
15) It is predicted from these studies that Cd 2þ specifically increases the production of IGFBP-1 with the participation of USFs. Our results are consistent with this deduction (Fig. 3) . The highest mRNA level of IGFBP-1 was that at 16 h. Dexamethasone, a potent synthetic glucocorticoid, increases IGFBP-1 mRNA expression for 3 h, 10) while amino acid deprivation causes a decrease in the level of IGFBP-1 mRNA for 24 h, as does administration of Cd 2þ . 16) These results suggest that it takes at least 6 h to activate USFs and/or IGFBP-1 by Cd 2þ . The reason is unknown. A time-course analysis of the production of USFs, a nuclear run-on assay, and luciferase assay of IGFBP-1 and USFs would surely aid in elucidating the mechanism underlying the increase in the mRNA levels of IGFBP-1 caused by Cd 2þ . Our results support the proposal that the detection of IGFBP-1 in serum has potential application as a biological marker of biologically effective doses similar to that of metallothionein. 17) Exposure to 100 ppm of oral cadmium increases levels of metallothionein mRNA in vivo. 18) In Japan, the concentration of Cd 2þ in food is regulated to be 1.0 ppm (8.9 mM) or less. Cd 2þ can be detected exactly and extensively by the use of both IGFBP-1 and metallothionein. Further studies, using rats in vivo, would help determine the importance of cadmium as an inducer of IGFBP-1 and the utility of IGFBP-1 as biological markers of cadmium.
In summary, a low dose of Cd 2þ was found drastically to increase the mRNA level of IGFBP-1 in HepG2. This change caused a remarkable increase in the production of IGFBP-1. These results should provide further basis for understanding the toxicity of cadmium. 
